GB
GB · GB · GB-APID-19172111000001106
Nalidixic acid 300mg/5ml oral suspension
ATC J01MB02
Last synced from NHS dm+d (United Kingdom) on
Identification
ManufacturerRosemont Pharmaceuticals Ltd
CountryGB (GB)
ATC codeJ01MB02
Dispensing—
ReimbursedNo
SourceNHS dm+d (United Kingdom)
Last synced6/5/2026
Packs · 1
- gtin5016119036897
Annotations
No annotations yet.
Raw payload (JSON)
{
"apid": "19172111000001106",
"desc": "Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)",
"form": "Oral suspension",
"vpid": "41952511000001106",
"source": "dmd",
"vtm_id": "776859002",
"strength": "60 mg",
"substance": "Nalidixic acid",
"ingredient": "Nalidixic acid",
"supplier_code": "2269501000001108"
}Related drugs
Other records sharing ATC code J01MB02.
- GBNalidixic acid 300mg/5ml oral suspensionAlliance Healthcare (Distribution) Ltd
- GBNalidixic acid 300mg/5ml oral suspensionEnnogen Healthcare Ltd
- FINalixanNEOFARMA
- FINalixanOrion Corporation Orion Pharma
- FINalixanOrion Corporation Orion Pharma
- FINalixanNEOFARMA
- FINegramGlaxo Wellcome Production
- FINegramSanofi-Synthelabo AB
Access this data programmatically
Query Nalidixic acid 300mg/5ml oral suspension and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.